Completed enrollment in DENALI Part 2a; dose confirmation expected in 1H 2026DENALI Part 2 trial topline readout expected by year end 2026; ...

Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.

JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...

A coalition of major nonprofit research organizations has awarded $2.1 million in grants to accelerate the development of ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

Heart disease is the leading cause of death in the United States. Since researchers first established the link between diet, ...

Sarah is an experienced writer and editor enthusiastic about helping readers live their healthiest and happiest lives. Before joining Forbes Health, Sarah worked as a writer for various digital ...

Biomarkers are now the currency of precision medicine and preventive health. Choose the partner that matches your goals, whether that is advancing a clinical trial, validating a new drug, or extending ...

Biomarker testing is foundational to successful targeted and immunotherapy development. From discovery to commercialization, strategic biomarker integration accelerates research and development, ...

Panelists discuss how biomarker development in anal cancer remains limited with PD-L1 status not influencing treatment decisions, although rare targets like HER2, PIK3CA aberrations, and RAS wild-type ...